Genmab — November 2020
-
AbbVie "So, Genmab, as an example, that filled the gap in hematological oncology that we had. And we wanted an important asset that could cover more areas of hem/onc to continue to drive our leadership position. So, we strategically went out and looked for a CD3xCD20." https://seekingalpha.com/article/4390402-abbvie-inc-abbv-presents-wolfe-research-healthcare-conference-transcript
-
God morgen.
-
USA Luk: Dow Jones 0,2 prosent
S&P 500 opp 0,4 prosent
Nasdaq Composite 0,9 prosent -
Fredagens aviser med Danske Bank, Mærsk og Vestas: https://www.proinvestor.com/investornyt/669779/fredagens-aviser-med-danske-bank-maersk-og-vestas
-
https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/ Bispecific Antibodies Poised to Impact Treatment of Lymphoma and Other Blood Cancers
-
Aktier/tendens: Flad åbning i sigte med fokus på Maersk Drillinghttps://www.proinvestor.com/investornyt/669792/aktier-tendens-flad-abning-i-sigte-med-fokus-pa-maersk-drilling
-
Spændende hvornår vi begynder marchen mod 3000...pt. et skridt frem...et tilbage.
-
Yes - helt som forventet
https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88742_2528.JPG -
@Pensionisten i have to say, Jan spoke reassuringly
calm and mature about the arbitration on that Jefferies fireside chat; normal part of business in biotech
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind